Protective effect of Heliotropium strigosum 70% aqueous methanolic extract against paracetamol induced hepatotoxicity in mice
The study was carried out to evaluate the hepatoprotective potential of aqueous methanolic extract of Heliotropium strigosum (HSME) against paracetamol induced hepatotoxicity in Swiss albino mice. The plant powder (1.5Kg) was macerated in aqueous methanol (30:70) for 7 days. The extract was evaluated for the presence of different phytochemicals and High-performance liquid chromatography (HPLC) analysis. HSME was orally administered to mice at 125, 250 and 500mg/kg for 8 days followed by paracetamol intoxication (500mg/kg orally) on the 8th day using silymarin as standard control. All the therapy was administered by oral gavage. The liver biochemical parameters and histopathological evaluation were carried out to assess changes in liver function and histology. HPLC analysis confirmed the presence of quercetin, kaempferol, and other phenolic compounds. Treatment with the extract resulted in notable (p<0.05) reduction in liver parameters in dose dependent manner. The action of HSME 500mg/kg dose was comparable to silymarin. The effect of HSME against paracetamol induced hepatotoxicity was demonstrated by protective changes in the liver histopathological which proved the traditional uses of the plant.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Pakistan journal of pharmaceutical sciences - 34(2021), 2(Supplementary) vom: März, Seite 693-698 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Saleem, Mohammad [VerfasserIn] |
---|
Themen: |
362O9ITL9D |
---|
Anmerkungen: |
Date Completed 30.12.2021 Date Revised 30.12.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM328211621 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328211621 | ||
003 | DE-627 | ||
005 | 20231225202459.0 | ||
007 | tu | ||
008 | 231225s2021 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n1094.xml |
035 | |a (DE-627)NLM328211621 | ||
035 | |a (NLM)34275804 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Saleem, Mohammad |e verfasserin |4 aut | |
245 | 1 | 0 | |a Protective effect of Heliotropium strigosum 70% aqueous methanolic extract against paracetamol induced hepatotoxicity in mice |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 30.12.2021 | ||
500 | |a Date Revised 30.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The study was carried out to evaluate the hepatoprotective potential of aqueous methanolic extract of Heliotropium strigosum (HSME) against paracetamol induced hepatotoxicity in Swiss albino mice. The plant powder (1.5Kg) was macerated in aqueous methanol (30:70) for 7 days. The extract was evaluated for the presence of different phytochemicals and High-performance liquid chromatography (HPLC) analysis. HSME was orally administered to mice at 125, 250 and 500mg/kg for 8 days followed by paracetamol intoxication (500mg/kg orally) on the 8th day using silymarin as standard control. All the therapy was administered by oral gavage. The liver biochemical parameters and histopathological evaluation were carried out to assess changes in liver function and histology. HPLC analysis confirmed the presence of quercetin, kaempferol, and other phenolic compounds. Treatment with the extract resulted in notable (p<0.05) reduction in liver parameters in dose dependent manner. The action of HSME 500mg/kg dose was comparable to silymarin. The effect of HSME against paracetamol induced hepatotoxicity was demonstrated by protective changes in the liver histopathological which proved the traditional uses of the plant | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Plant Extracts |2 NLM | |
650 | 7 | |a Silymarin |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
650 | 7 | |a Methanol |2 NLM | |
650 | 7 | |a Y4S76JWI15 |2 NLM | |
700 | 1 | |a Nain, Hira |e verfasserin |4 aut | |
700 | 1 | |a Akhtar, Muhammad Furqan |e verfasserin |4 aut | |
700 | 1 | |a Saleem, Ammara |e verfasserin |4 aut | |
700 | 1 | |a Saadullah, Malik |e verfasserin |4 aut | |
700 | 1 | |a Mobashar, Aisha |e verfasserin |4 aut | |
700 | 1 | |a Rasul, Azhar |e verfasserin |4 aut | |
700 | 1 | |a Shah, Muhammad Ajmal |e verfasserin |4 aut | |
700 | 1 | |a Hamid, Irfan |e verfasserin |4 aut | |
700 | 1 | |a Iqbal, Rabia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pakistan journal of pharmaceutical sciences |d 1988 |g 34(2021), 2(Supplementary) vom: März, Seite 693-698 |w (DE-627)NLM09369900X |x 1011-601X |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2021 |g number:2(Supplementary) |g month:03 |g pages:693-698 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2021 |e 2(Supplementary) |c 03 |h 693-698 |